Axelrod J H, Reich R, Miskin R
Department of Biochemistry, Weizmann Institute of Science, Rehovot, Israel.
Mol Cell Biol. 1989 May;9(5):2133-41. doi: 10.1128/mcb.9.5.2133-2141.1989.
The gene transfer technique was used to examine the role of plasminogen activator (PA) in the invasive and metastatic behavior of tumorigenic cells. H-ras-transformed NIH 3T3 clonal cells producing a very low level of PA were generated and further transfected with an expression plasmid containing a cDNA sequence encoding either the urokinase-type or the tissue-type human PA. Compared with the parental transformed cells, clonal cells expressing high levels of both types of recombinant PA invaded more rapidly through a basement membrane reconstituted in vitro. Furthermore, cells expressing high levels of recombinant urokinase-type PA also caused a higher incidence of pulmonary metastatic lesions after intravenous injection into nude mice. Both activities were reduced by the serine proteinase inhibitor EACA; invasion was also suppressed by antibodies blocking the activity of human PAs and by the synthetic collagenase inhibitor SC-44463. These findings provide direct genetic evidence for a causal role of PA in invasive and metastatic activities.
基因转移技术被用于研究纤溶酶原激活剂(PA)在致瘤细胞侵袭和转移行为中的作用。生成了产生极低水平PA的H-ras转化的NIH 3T3克隆细胞,并进一步用含有编码尿激酶型或组织型人PA的cDNA序列的表达质粒进行转染。与亲代转化细胞相比,表达高水平两种重组PA的克隆细胞通过体外重建的基底膜侵袭更快。此外,表达高水平重组尿激酶型PA的细胞在静脉注射到裸鼠后也导致更高的肺转移病变发生率。两种活性都被丝氨酸蛋白酶抑制剂EACA降低;侵袭也被阻断人PA活性的抗体和合成胶原酶抑制剂SC-44463抑制。这些发现为PA在侵袭和转移活动中的因果作用提供了直接的遗传学证据。